J07AE02 - Cholera, Live Attenuated

Propably not porphyrinogenic

Rationale

Based on the pharmacokinetics of the Live attenuated cholera vaccine, no porphyrinogenic effects are expected.

Chemical description

Live attenuated virus vaccine.

Therapeutic characteristics

Indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older. The vaccine is administered orally.

Metabolism and pharmacokinetics

Vaccines are not metabolized by the cytochrome P450 system.

Similar drugs

Explore alternative drugs in similar therapeutic classes J07A / J07AE or go back.

References

#	Citation details	PMID
*	Government bodies
1.	European Medicines Agency (EMA). SmPC Vaxchora.
2.	Norwegian institute of public health. Vaccines and vaccination.

Citation details

PMID

Government bodies

European Medicines Agency (EMA). SmPC Vaxchora.

Norwegian institute of public health. Vaccines and vaccination.

Tradenames

Show more details and information about the listed tradenames

Vaxchora

Vaxchora vaccine

Vaxchora

Vaccines

In cooperation with IpNet

Acute Porphyria Drugs

J07AE02 - Cholera, Live Attenuated